Navigation Links
Common human viruses threaten endangered great apes
Date:1/25/2008

Common human viruses are responsible for outbreaks of respiratory disease that have led to the decline of endangered chimpanzees in the wild, according to a study reported online on January 24th in Current Biology, a publication of Cell Press. The findingswhich are the first to provide direct evidence of virus transmission from humans to wild great apesillustrate the challenge of maximizing the benefit of research and tourism to great apes while minimizing the negative side effects that come with human contact, the researchers say.

Research and tourism has a strong positive effect on great apes survival since it reduces poaching activities in these areas and gives more political weight to the apes and protected areas, said Fabian Leendertz of Robert Koch-Institut and Max Planck Institute for Evolutionary Anthropology in Germany. [The spread of viruses] has been a concern, but people had never proven it. Our demographic analyses of chimpanzees suggest that this started as soon as people got close enough to chimps to transmit diseases. There is a correlation between habituationthe proximity between humans and chimpsand disease outbreaks.

Commercial hunting and habitat loss are major drivers of the rapid decline of great apes, the researchers said. Ecotourism and research have been widely promoted as a means of providing alternative value for apes and their habitats. While close contact between humans and habituated apes has raised concerns about disease transmission, previous studies had only demonstrated the spread of relatively mild bacterial and parasitic infections from humans to wild apes.

In the new study, the researchers gathered evidence from chimpanzees hit by five distinct respiratory outbreaks between 1999 and 2006 in Cte d'Ivoire, West Africa. The outbreaks sickened almost all of the chimps and led to a significant number of deaths.

All available tissue samples taken from chimps who had died tested positive for one of two paramyxoviruses: human respiratory syncytial virus (HRSV) or human metapneumovirus (HMPV), the researchers report. HRSV and HMPV are common causes of respiratory disease in humans and are the leading causes of lower respiratory disease in children and, in developing countries, a major source of infant mortality, the researchers said. In adults, HRSV and HMPV usually cause mild upper-respiratory-tract infection but can lead to more serious illnesses such as pneumonia.

The viruses we found are very common, Leendertz said. Antibody prevalence in humans is almost up to 100 percent, meaning almost everybody has had contact with these viruses.

Twenty-four years of mortality data from observed chimpanzees revealed that such respiratory outbreaks could have a long history, Leendertzs team reported. But, they added, there was some good news: Survey data show that research presence has had a strong positive effect in suppressing poaching around the research site.

The researchers have already stepped up guidelines to help minimize the disease risk to chimpanzees, and they urge others to do the same. For example, Leendertz said, they now maintain a distance of at least seven meters, wear masks, and disinfect their boots regularly.


'/>"/>

Contact: Cathleen Genova
cgenova@cell.com
617-397-2802
Cell Press
Source:Eurekalert

Related medicine news :

1. Wyeth Declares Common and Preferred Stock Dividends
2. MiddleBrook Pharmaceuticals to Raise $21 Million Through Private Placement of Common Equity
3. Rigel Announces Offering of 4,000,000 Shares of Common Stock
4. Infection With Common Parasite Raises Schizophrenia Risk
5. Surgical site infections more common than expected following breast procedures
6. Schering-Plough CEO to Buy $2 Million in Common Shares
7. Common molecule notifies immune system of prostate cancer
8. GHI and HIP Launch Pilot Medical Home Network Project with Support from Commonwealth Fund
9. Multiple skin cancer risk behaviors are common among US adults
10. Catheter chaos: Hospitals lag in preventing common infection
11. Colon cancer risk in US traced to common ancester
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... Coveros, a leader in ... awarded a contract by the Center for Medicare and Medicaid Services (CMS). The ... enterprise use of Agile methodologies in a consistent and high value manner across ...
(Date:10/12/2017)... Francisco, CA (PRWEB) , ... October 12, 2017 ... ... Dr. Cheng, are now treating sleep apnea using cutting-edge Oventus O2Vent ... apnea, a serious sleep disorder characterized by frequent cessation in breathing. Oral appliances ...
(Date:10/12/2017)... ... October 12, 2017 , ... The American College of Medical ... Friedman, PhD, FACMI, during the Opening Session of AMIA’s Annual Symposium in Washington, D.C. ... honor of Morris F. Collen, a pioneer in the field of medical informatics, this ...
(Date:10/12/2017)... Malvern, PA (PRWEB) , ... October 12, 2017 , ... ... is the recipient of a 2017 Folio Magazine Eddie Digital Award for ‘Best ... New York City on October 11, 2017. , The annual award competition recognizes editorial ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... (HLA), the nation's first interactive health literacy software tool, and the Cancer Patient ... aspects of cancer patient education, today announce a new strategic alliance. , ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... Mich. , Oct. 2, 2017 Diplomat ... 8th Day Software and Consulting, LLC , and ... 8th Day Software, based in Tennessee ... LLC. 8th Day expands EnvoyHealth,s service offerings for health ... development. "In an ...
(Date:9/28/2017)... Sept. 28, 2017 Hill-Rom Holdings, Inc. (NYSE: ... conference call and webcast on Friday, November 3, 2017, ... and ending at approximately 8:30 a.m. (CDT) / 9:30 ... company,s 2017 financial performance and guidance for 2018, Hill-Rom ... to enhance operational performance, and long-range financial outlook through ...
(Date:9/25/2017)... , Sept. 25, 2017  EpiVax, Inc., ... vaccine design, and immune-engineering today announced the launch ... the development of personalized therapeutic cancer vaccines. EpiVax ... provided exclusive access to enabling technologies to the ... MBA will lead EpiVax Oncology as Chief Executive ...
Breaking Medicine Technology: